Vitrafy Life Sciences Limited (ASX:VFY)

Vitrafy Life Sciences Revenue

In the fiscal year ending June 30, 2026, Vitrafy Life Sciences had annual revenue of 3.66M AUD with 101.02% growth. Vitrafy Life Sciences had revenue of 1.98M in the half year ending December 31, 2025, with 64.59% growth.

• Revenue: 3.66M
• Revenue Growth: +80.04%
• P/S Ratio: 80.19
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 293.37M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	3.66M	1.84M	101.02%
Jun 30, 2025	1.82M	-273.57K	-13.07%
Jun 30, 2024	2.09M	37.10K	1.80%
Jun 30, 2023	2.06M	230.64K	12.63%
Jun 30, 2022	1.83M	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 6, 2026

Data Sources Report a data error